BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
BioLoomics has raised $8.7M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
BioLoomics's investors include Hummingbird Ventures, Innovation Endeavors, TechU Ventures, BoxOne Ventures, Boom Capital Ventures.
BioLoomics is headquartered in Boulder, United States.
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
BioLoomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioLoomics — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/bioloomics. Accessed July 20, 2026.
VCBacked. (2023). BioLoomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/bioloomics
{{cite web |title=BioLoomics — Funding & Investors |url=https://www.vcbacked.co/company/bioloomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated